I imagine the TGA approval will come through at some point - which will prove a share price sweetener, which will quickly be sold off. The FDA FebriDX approval won't come until end of year (and that's uncertain in itself).
What is needed is meaningful agreements that lead to meaningful growth and sustained earnings. I think we are several years off from seeing this - hopefully sooner.
I still remain positive and patient with Atomo.
AT1 FY21 - General Discussion + FA, page-2241
-
- There are more pages in this discussion • 193 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
